Director's Dealings

CEL AI

15/01/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240115:nRSO6117Za&default-theme=true

RNS Number : 6117Z  Cellular Goods PLC  15 January 2024

The information contained within this announcement is deemed by the Company to
constitute inside information stipulated under the Market Abuse Regulation
(EU) No. 596/2014, as retained as part of the law of England and Wales. Upon
the publication of this announcement via the Regulatory Information Service,
this inside information is now considered to be in the public domain.

 

15 January 2024

Cellular Goods PLC

("Cellular Goods" or "The Company")

Director's Dealings

 

Cellular Goods (LSE: CBX), a UK-based company pioneering the use of lab-based
and biosynthetic production methods for wellness and sustainability solutions,
announces that Michael Edwards (Executive Director of Cellular Goods) has
purchased a total of 833,333 ordinary shares in the Company ("Ordinary
Shares"), the details of which are set out in the notification below.
Following this purchase, Michael Edwards holds a total of 10,233,333 Ordinary
Shares, representing 1.7 per cent of the Company's issued share capital.

 

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them.

 

 1.  Details of the person discharging managerial responsibilities / person closely
     associated
 a)  Name                                                         Michael Edwards
 2.  Reason for the Notification
 a)  Position/status                                              Executive Director
 b)  Initial notification / Amendment                             Initial notification
 3.  Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         Cellular Goods PLC
 b)  LEI                                                          213800IXPX4Z2MKX2U28
 4.  Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the Financial instrument, type of instrument  Ordinary shares
     Identification Code                                          GB00BK964W87
 b)  Nature of the transaction                                    Purchase of shares
 c)  Price(s) and volume(s)                                       Price(s)                        Volume(s)
                                                                  0.594 pence per Ordinary Share  833,333 Ordinary Shares
 d)  Aggregated information:

     · Aggregated volume                                          833,333 Ordinary Shares

     · Price                                                      0.594 pence per Ordinary Share
 e)  Date of the transaction                                      12 January 2024
 f)  Place of the Transaction                                     London Stock Exchange

d)

Aggregated information:

· Aggregated volume

· Price

 

833,333 Ordinary Shares

0.594 pence per Ordinary Share

e)

Date of the transaction

12 January 2024

f)

Place of the Transaction

London Stock Exchange

 

 

 

For further information please contact:

 Cellular Goods
 Michael Edwards                                              via FSCF +44 7572 873 300

 Director
 First Sentinel Corporate Finance (FSCF)
 Investor Relations

 Rebecca Noonan                                               +44 7572 873 300

 IR@cellular-goods.com (mailto:IR@cellular-goods.com)

 Media Relations

 Rebecca Noonan                                               +44 7572 873 300

 Media@cellular-goods.com (mailto:Media@cellular-goods.com)

 Corporate Broker & Advisor

 Brian Stockbridge                                            +44 7858 888 007
 Novum Securities
 Corporate Broker

 Colin Rowbury

 Jon Belliss                                                  +44 207 399 9427

 

 

About Cellular Goods PLC:

Cellular Goods is pioneering the use of lab-based and biosynthetic production
methods for wellness and sustainability solutions. The Company launched with a
focus on efficacy led and science-backed products utilising biosynthetics, and
now employs its expertise across two verticals: premium next-generation
cannabinoid skincare products, and carbon sequestration-as-a-service through
its wholly owned business division, King Tide Carbon, which utilises
biosynthetic algae and seaweed to provide scalable carbon removal. The Company
is incorporated in the UK and listed on the Main Market of the London Stock
Exchange. For more information, visit www.cellular-goods.com
(http://www.cellular-goods.com) .

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHGPUWAGUPCGPC